Axatilimab FDA approval date

The FDA approved Axatilimab (Niktimvo) on 14 Aug 2024.

FDA approval date
14 Aug 2024

Drug identity checked against registry records

Also recorded as Niktimvo; SNDX-6352

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-08-14DayAxatilimabFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761411", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["NIKTIMVO"], "active_ingredients": ["axatilimab-csfr"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240814", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026